PET/CT in Paediatric Oncology: Indications and Pitfalls

Overview

Journal Pediatr Radiol

Specialty Pediatrics

Date 2009 May 15

PMID 19440764

Citations 5

Authors

Christiane Franzius

Kai Uwe Juergens

Affiliations

Soon will be listed here.

Citing Articles

Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology.

Aydos U, Balci E, Gulbahar Ates S, Akdemir U, Karadeniz C, Atay L Turk J Med Sci. 2023; 53(1):289-302.

PMID: 36945939 PMC: 10387842. DOI: 10.55730/1300-0144.5584.

Defining optimal tracer activities in pediatric oncologic whole-body F-FDG-PET/MRI.

Gatidis S, Schmidt H, Fougere C, Nikolaou K, Schwenzer N, Schafer J Eur J Nucl Med Mol Imaging. 2016; 43(13):2283-2289.

PMID: 27565153 DOI: 10.1007/s00259-016-3503-5.

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Bleeker G, Tytgat G, Adam J, Caron H, Kremer L, Hooft L Cochrane Database Syst Rev. 2015; (9):CD009263.

PMID: 26417712 PMC: 4621955. DOI: 10.1002/14651858.CD009263.pub2.

Diagnostic value of combined ¹⁸F-FDG PET/MRI for staging and restaging in paediatric oncology.

Pfluger T, Melzer H, Mueller W, Coppenrath E, Bartenstein P, Albert M Eur J Nucl Med Mol Imaging. 2012; 39(11):1745-55.

PMID: 22926713 DOI: 10.1007/s00259-012-2228-3.

Imaging pediatric bone sarcomas.

Kaste S Radiol Clin North Am. 2011; 49(4):749-65, vi-vii.

PMID: 21807172 PMC: 4725719. DOI: 10.1016/j.rcl.2011.05.006.

References

Hawkins D, Rajendran J, Conrad 3rd E, Bruckner J, Eary J . Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer. 2002; 94(12):3277-84. DOI: 10.1002/cncr.10599. View

Kuehl H, Antoch G . How much CT do we need for PEt/CT? A radiologist's perspective. Nuklearmedizin. 2006; 44 Suppl 1:S24-31. View

Korholz D, Claviez A, Hasenclever D, Kluge R, Hirsch W, Kamprad F . The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. Klin Padiatr. 2004; 216(3):150-6. DOI: 10.1055/s-2004-822627. View

Hudson M, Krasin M, Kaste S . PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol. 2004; 34(3):190-8. DOI: 10.1007/s00247-003-1114-3. View

Pages J, Buls N, Osteaux M . CT doses in children: a multicentre study. Br J Radiol. 2003; 76(911):803-11. DOI: 10.1259/bjr/92706933. View

Brenner D, Elliston C, Hall E, BERDON W . Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001; 176(2):289-96. DOI: 10.2214/ajr.176.2.1760289. View

Hahn K, Pfluger T . Is PET/CT necessary in paediatric oncology? Against. Eur J Nucl Med Mol Imaging. 2006; 33(8):966-8. DOI: 10.1007/s00259-006-0115-5. View

Gerth H, Juergens K, Dirksen U, Gerss J, Schober O, Franzius C . Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. J Nucl Med. 2007; 48(12):1932-9. DOI: 10.2967/jnumed.107.045286. View

Paterson A, Frush D, Donnelly L . Helical CT of the body: are settings adjusted for pediatric patients?. AJR Am J Roentgenol. 2001; 176(2):297-301. DOI: 10.2214/ajr.176.2.1760297. View

10.

Franzius C, Riemann B, Vormoor J, Kopka K, Wagner S, Rath B . Metastatic neuroblastoma demonstrated by whole-body PET-CT using 11C-HED. Nuklearmedizin. 2005; 44(1):N4-5. View

11.

Lucas J, ODoherty M, Wong J, Bingham J, McKee P, Fletcher C . Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br. 1998; 80(3):441-7. DOI: 10.1302/0301-620x.80b3.8232. View

12.

Stauss J, Franzius C, Pfluger T, Juergens K, Biassoni L, Begent J . Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging. 2008; 35(8):1581-8. DOI: 10.1007/s00259-008-0826-x. View

13.

Krasin M, Hudson M, Kaste S . Positron emission tomography in pediatric radiation oncology: integration in the treatment-planning process. Pediatr Radiol. 2004; 34(3):214-21. DOI: 10.1007/s00247-003-1113-4. View

14.

Rogalla P, Stover B, Scheer I, Juran R, Gaedicke G, Hamm B . Low-dose spiral CT: applicability to paediatric chest imaging. Pediatr Radiol. 1999; 29(8):565-9. DOI: 10.1007/s002470050648. View

15.

Hermann S, Wormanns D, Pixberg M, Hunold A, Heindel W, Jurgens H . Staging in childhood lymphoma: differences between FDG-PET and CT. Nuklearmedizin. 2005; 44(1):1-7. DOI: 10.1267/nukl05010001. View

16.

Kaste S . Issues specific to implementing PET-CT for pediatric oncology: what we have learned along the way. Pediatr Radiol. 2004; 34(3):205-13. DOI: 10.1007/s00247-003-1111-6. View

17.

Franzius C, Daldrup-Link H, Wagner-Bohn A, Sciuk J, Heindel W, Jurgens H . FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol. 2002; 13(1):157-60. DOI: 10.1093/annonc/mdf012. View

18.

Honnef D, Wildberger J, Stargardt A, Hohl C, Barker M, Gunther R . [Multislice spiral CT (MSCT) in pediatric radiology: dose reduction for chest and abdomen examinations]. Rofo. 2004; 176(7):1021-30. DOI: 10.1055/s-2004-813198. View

19.

Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O . Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med. 2000; 25(11):874-81. DOI: 10.1097/00003072-200011000-00004. View

20.

Wegner E, Barrington S, Kingston J, Robinson R, Ferner R, Taj M . The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging. 2004; 32(1):23-30. DOI: 10.1007/s00259-004-1645-3. View